Related Experiment Video
Updated: May 26, 2026
04:36
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
Peripartum cardiomyopathy: a review article
Kamilu M Karaye1, Michael Y Henein
1Department of Medicine, Bayero University, Kano, Nigeria. kkaraye@yahoo.co.uk
International Journal of Cardiology
|December 24, 2011
Summary
Peripartum cardiomyopathy (PPCM) is a serious heart condition affecting women during pregnancy or postpartum. This review explores its epidemiology, causes, and management strategies.
Area of Science:
- Cardiology
- Obstetrics
- Maternal Health
Background:
- Peripartum cardiomyopathy (PPCM) is a rare but severe heart condition.
- It presents significant morbidity and mortality globally, with notable geographic variations.
- The exact causes and mechanisms of PPCM remain largely unknown.
Purpose of the Study:
- To provide a comprehensive overview of Peripartum cardiomyopathy (PPCM).
- To discuss current understanding of PPCM's epidemiology, risk factors, and etiology.
- To review diagnostic methods, treatment options, and prognostic factors for PPCM.
Main Methods:
- This study is a review of existing literature on Peripartum cardiomyopathy (PPCM).
- It synthesizes information on various proposed etiological hypotheses, including myocarditis, prolactin, autoimmunity, and genetics.
- The review also examines the potential utility of advanced echocardiographic techniques.
Main Results:
- PPCM exhibits significant global prevalence disparities.
- Multiple hypotheses exist regarding PPCM's origins, but none are definitively proven.
- Echocardiography plays a crucial role in diagnosis and monitoring.
Conclusions:
- Further research is needed to elucidate the precise etiology and pathogenesis of Peripartum cardiomyopathy (PPCM).
- Early diagnosis and appropriate management are critical for improving patient outcomes.
- Novel diagnostic tools, like advanced echocardiography, may offer new insights.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...